Future progress in improving cancer therapy can be expedited by better prioritization of new treatments for phase III evaluation. Historically, phase II trials have been key components in the ...
Zipalertinib in Patients With Epidermal Growth Factor Receptor Exon 20 Insertion-Positive Non–Small Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy With or Without Amivantamab ...
The authors sought to understand the differential impact of payer-led community-based care management approaches on stakeholder-oriented outcomes for publicly insured adults with multiple chronic ...
Bertoli, Andrew, Laura Jakli, and Henry Pascoe. "Analyzing the Impact of Events Through Surveys: Formalizing Biases and Introducing the Dual Randomized Survey Design." Political Science Research and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results